Johnson Chemical Pharmaceutical Works Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 13, 2023 at 04:00 am
Share
Johnson Chemical Pharmaceutical Works Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 148.02 million compared to TWD 126.58 million a year ago. Net income was TWD 17.19 million compared to TWD 19.24 million a year ago. Basic earnings per share from continuing operations was TWD 0.45 compared to TWD 0.64 a year ago. Diluted earnings per share from continuing operations was TWD 0.44 compared to TWD 0.64 a year ago.
For the nine months, sales was TWD 451.98 million compared to TWD 353.54 million a year ago. Net income was TWD 62.08 million compared to TWD 46.3 million a year ago. Basic earnings per share from continuing operations was TWD 1.9 compared to TWD 1.54 a year ago. Diluted earnings per share from continuing operations was TWD 1.81 compared to TWD 1.54 a year ago.
Johnson Chemical Pharmaceutical Works Co., Ltd. is a Taiwan-based company principally engaged in the manufacture and distribution of western medicines and the related raw materials. The Company mainly provides solid dosage forms, including soft and hard capsules, sugar coated tablets, film-coated tablets, suppositories, powder, granules, tablets and others. The Companyâs products include central nervous system drugs, hormones and hormone function medicines, respiratory medicines, gastrointestinal drugs, vitamins and others. The Company mainly distributes its products in Taiwan market and the rest of Asia.
JOHNSON CHEMICAL PHARMACEUTICAL WORKS CO., LTD. 
